Patient information:
Vaniqa is a light cream approved to treat the growth of unwanted facial hair in female individuals. It reduces hair growth in time and works on hair follicle, unlike traditional hair removal methods which do not interfere with hair growth, only with its appearance. However, at least for the first 8 weeks of treatment, Vaniqa should be used as supplement of other hair removal products.
Vaniqa suits all
complexion types, yet users should priory ask for dermatologist’s
advice.
The effects of Vaniqa are due to its activity spectrum focused
directly on the enzymes
found in follicles and responsible for hair growth. By blocking these
enzymes, hair is inhibited in time from growing. The inhibition action
occurs during the growth process.
Directions of using Vaniqa:
Vaniqa offers noticeable results within 6 to 8 weeks of treatment, as prescribed, twice a day every day on thoroughly cleansed and dry skin. After applying it, users are indicated to apply sun block and moisturizing products. A small amount of cream applied evenly on the targeted area should suffice for optimum results. Applications are advisable at 8 hour minimum intervals. Skin must not be cleansed at least 4 hours since last application.
During treatment, unwanted facial hair will still appear and need removal. In time, its growth rate and thickness will be decreased. If Vaniqa treatment is ended before the treatment period it is completed, hair will enhance it usual growth rate and results will no longer be visible. After extended time spans, Vaniqa will need less frequent use. Vaniqa is proven to increase the effectiveness in association with laser hair removal methods within 6 to 22 weeks of use.
Contraindications to Vaniqa:
Vaniqa should not be use by pregnant women, if you are pregnant, attempting to become pregnant or if are breast feeding.
Vaniqa's Side Effects:
Vaniqa may also induce adverse reactions during treatment. Skin irritation revealed as local redness and burning, rashes or stinging and even acne are most commonly reported side effects of the cream while clinically tested. However, reactions were in more than 98% of the cases tolerable and temporary. If these effects persist, a dermatologist should be consulted or the treatment should be ceased.